https://doi.org/10.4081/reumatismo.2013.721

Intra-articular therapy with tumor necrosis factor-α antagonists: an update

Vol. 65 No. 6 (2013)
Submitted: 27 September 2013
Accepted: 10 February 2014
Published: 14 March 2014
intra-articular therapy, sieronegative spondyloarthritis, anti-TNF agents, refractory monoarthritis.
Abstract Views: 2401
PDF: 1175
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

S. Bello
s.bello1@virgilio.it
Rheumatology Unit, Policlinico Hospital, University of Bari, Italy.
C. Bonali
Rheumatology Unit, Policlinico Hospital, University of Bari, Italy.
L. Serafino
Rheumatology Unit, Policlinico Hospital, University of Bari, .
C. Rotondo
Rheumatology Unit, Policlinico Hospital, University of Bari, .
N. Terlizzi
Rheumatology Unit, Policlinico Hospital, University of Bari, .
G. Lapadula
Rheumatology Unit, Policlinico Hospital, University of Bari, Italy.
The aim of the study was to review from the present literature the intra-articular (IA) use of the TNF-blocking drugs. A total of 28 papers about this topic were found through a search in PubMed; the first publication’s date was July 2003. These studies include a total of 214 patients affected by 12 different joint diseases that reported a total of 1046 intra-articular therapies carried out in 10 different joint sites. Infliximab and etanercept were the most widely used medications. The safety of this treatment clearly emerges from our analysis, while more difficult was the evaluation of its efficacy. Nevertheless we deduced an ideal patient profile that may better respond to the IA anti-TNF treatment.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC

Supporting Agencies

none
S. Bello, Rheumatology Unit, Policlinico Hospital, University of Bari
Già borsista,attualmente collaboratore esterno con finalità di ricerca,presso ambulatorio dedicato alle terapie biologiche,

How to Cite

Bello, S., Bonali, C., Serafino, L., Rotondo, C., Terlizzi, N., & Lapadula, G. (2014). Intra-articular therapy with tumor necrosis factor-α antagonists: an update. Reumatismo, 65(6), 257–263. https://doi.org/10.4081/reumatismo.2013.721

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.

Similar Articles

<< < 1 2 3 4 5 6 7 8 9 10 > >> 

You may also start an advanced similarity search for this article.